c-Met/HGFR
c-Met/HGFR inhibitors target the Hepatocyte Growth Factor Receptor (c-Met), a tyrosine kinase involved in cellular processes such as growth, motility, and morphogenesis. c-Met signaling is implicated in cancer progression, metastasis, and resistance to therapies. Inhibiting c-Met can disrupt tumor growth and spread, making these inhibitors valuable in cancer research. At CymitQuimica, we offer c-Met/HGFR inhibitors to support your research in oncology, metastasis, and targeted cancer therapies.
Read more
Pamufetinib
CAS:1190836-34-0
Pamufetinib (TAS-115) is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase.
Formula:
C27H23FN4O4S
Purity:
99.39%
Color and Shape:
Solid
Molecular weight:
518.56
Ref: TM-T13108
| 1mg | 50.00 € | ||
| 5mg | 106.00 € | ||
| 10mg | 158.00 € | ||
| 25mg | 258.00 € | ||
| 50mg | 379.00 € | ||
| 100mg | 538.00 € | ||
| 200mg | 733.00 € | ||
| 1mL*10mM (DMSO) | 134.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
Bozitinib
CAS:1440964-89-5
Bozitinib (PLB-1001) (PLB-1001) is a highly selective inhibitor of the c-MET kinase with blood-brain barrier …
Formula:
C20H15F3N8
Purity:
99.16%
Color and Shape:
Solid
Molecular weight:
424.38
Ref: TM-T10585
| 1mg | 106.00 € | ||
| 5mg | 216.00 € | ||
| 10mg | 354.00 € | ||
| 25mg | 628.00 € | ||
| 50mg | 905.00 € | ||
| 100mg | 1,264.00 € | ||
| 1mL*10mM (DMSO) | 240.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
BMS-777607
CAS:1196681-44-3
BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3.
Formula:
C25H19ClF2N4O4
Color and Shape:
Solid
Molecular weight:
512.89
Ref: TM-T2658
| 2mg | 63.00 € | ||
| 5mg | 90.00 € | ||
| 10mg | 142.00 € | ||
| 25mg | 265.00 € | ||
| 50mg | 409.00 € | ||
| 100mg | 727.00 € | ||
| 200mg | 1,091.00 € | ||
| 500mg | 1,636.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
JNJ-38877618
CAS:943540-74-7
JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and …
Formula:
C20H12F2N6
Purity:
98.84% - 99.52%
Color and Shape:
Solid
Molecular weight:
374.35
Ref: TM-T15617
| 1mg | 63.00 € | ||
| 2mg | 89.00 € | ||
| 5mg | 137.00 € | ||
| 10mg | 210.00 € | ||
| 25mg | 424.00 € | ||
| 50mg | 627.00 € | ||
| 100mg | 893.00 € | ||
| 500mg | 1,786.00 € | ||
| 1mL*10mM (DMSO) | 153.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
CSF1R-IN-2
CAS:2271119-26-5
CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and …
Formula:
C20H20FN7O2
Purity:
99.29%
Color and Shape:
Solid
Molecular weight:
409.42
Ref: TM-T13194
| 1mg | 46.00 € | ||
| 5mg | 92.00 € | ||
| 10mg | 131.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 353.00 € | ||
| 100mg | 500.00 € | ||
| 1mL*10mM (DMSO) | 99.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
c-Met inhibitor 1
CAS:1357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of …
Formula:
C17H14N8S
Purity:
98.77%
Color and Shape:
Solid
Molecular weight:
362.41
Ref: TM-T10655
| 1mg | 85.00 € | ||
| 5mg | 172.00 € | ||
| 10mg | 236.00 € | ||
| 25mg | 398.00 € | ||
| 50mg | 588.00 € | ||
| 100mg | 838.00 € | ||
| 1mL*10mM (DMSO) | 188.00 € |
Estimated delivery in United States, on Wednesday 9 Apr 2025
MET/PDGFRA-IN-1
MET/PDGFRA-IN-1 (compound 8c) serves as an inhibitor of MET and PDGFRA proteins, displaying an IC50 …
Formula:
C26H23N7O
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
449.51
Ref: TM-T78843
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
Davutamig
CAS:2648058-48-2
Davutamig (REGN-5093) is a humanized IgG4-kappa, anti-MET monoclonal antibody that binds to two distinct, nonoverlapping …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T82608
| 1mg | To inquire | ||
| 5mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
PF-04217903 phenolsulfonate
CAS:1159490-85-3
PF-04217903 phenolsulfonate is a potent ATP-competitive inhibitor of c-Met kinase (Ki of 4.8 nM for …
Formula:
C25H22N8O5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
546.56
Ref: TM-T12418
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
Narnatumab
CAS:1188275-92-4
Narnatumab (IMC-RON8) is a humanized antibody targeting the macrophage-stimulating receptor (RON) with antitumor activity, used …
Color and Shape:
Liquid
Ref: TM-T77409
| 1mg | 460.00 € | ||
| 5mg | 1,418.00 € | ||
| 10mg | 2,196.00 € | ||
| 25mg | 4,126.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
PROTAC c-Met degrader-1
CAS:3056647-52-7
PROTACc-Met degrader-1 (Compound Met-DD4) is an orally effective PROTAC degrader targeting c-Met with a DC50 …
Formula:
C45H41FN10O5
Color and Shape:
Liquid
Molecular weight:
820.87
Ref: TM-T201057
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
Rilotumumab
CAS:872514-65-3
Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC …
Purity:
SDS-PAGE:95% SEC-HPLC:97.51%
Color and Shape:
Liquid
Molecular weight:
145.2 kDa
Ref: TM-T76758
| 1mg | 243.00 € | ||
| 5mg | 635.00 € | ||
| 10mg | 1,017.00 € | ||
| 25mg | 1,501.00 € | ||
| 50mg | 2,023.00 € | ||
| 100mg | 2,737.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
Emibetuzumab
CAS:1365287-97-3
Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
Purity:
SDS-PAGE:96.2%;SEC-HPLC:98.8%
Color and Shape:
Liquid
Molecular weight:
143.74 kDa
Ref: TM-T76743
| 1mg | 144.00 € | ||
| 5mg | 424.00 € | ||
| 10mg | 677.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
c-Met-IN-18
C-Met-IN-18, an ATP-competitive type-III inhibitor, targets both wild-type (WT) and D1228V mutant c-MET with IC50 …
Formula:
C21H15FN4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
374.37
Ref: TM-T78934
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
Telisotuzumab
CAS:1781223-80-0
Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with …
Purity:
SDS-PAGE:96.4%;SEC-HPLC:98.5%
Color and Shape:
Liquid
Molecular weight:
145.50 kDa
Ref: TM-T77437
| 1mg | 354.00 € | ||
| 5mg | 887.00 € | ||
| 10mg | 1,415.00 € | ||
| 25mg | 2,080.00 € | ||
| 50mg | 2,822.00 € | ||
| 100mg | 3,734.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
c-Met-IN-19
c-Met-IN-19 (Compound 21j) is a potent c-Met inhibitor with an IC50 of 1.99 nM and …
Formula:
C34H37Cl2FN4O7S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
735.65
Ref: TM-T79715
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
C-Met inhibitor D9
CAS:299405-67-7
C-Met inhibitor D9 is a c-Met kinase inhibitor.
Formula:
C17H15N3O2
Purity:
97%
Color and Shape:
Liquid
Molecular weight:
293.32
Ref: TM-T67859
| 1mg | 185.00 € | ||
| 5mg | 425.00 € | ||
| 10mg | 625.00 € | ||
| 25mg | 938.00 € | ||
| 50mg | 1,311.00 € | ||
| 100mg | 1,795.00 € | ||
| 500mg | 3,591.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
c-Met-IN-17
c-Met-IN-17 is a potent inhibitor of c-Met kinase, demonstrating an IC50 of 0.031 μM, and …
Formula:
C21H15FN4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
374.37
Ref: TM-T79142
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 10 Apr 2025
LMTK3-IN-1
CAS:2764850-23-7
Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades …
Formula:
C18H11F3N4O
Purity:
100%
Color and Shape:
Soild
Molecular weight:
356.3
Ref: TM-T77620
| 1mg | 52.00 € | ||
| 5mg | 111.00 € | ||
| 10mg | 170.00 € | ||
| 25mg | 283.00 € | ||
| 50mg | 430.00 € | ||
| 100mg | 622.00 € | ||
| 500mg | 1,293.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
Onartuzumab
CAS:1133766-06-9
Onartuzumab (MetMAb) is a humanized monoclonal antibody targeting c-MET, with antitumor effects by blocking HGF …
Purity:
97.3%
Color and Shape:
Liquid
Molecular weight:
146.99 kDa
Ref: TM-T76780
| 1mg | 427.00 € | ||
| 5mg | 1,768.00 € | ||
| 10mg | 2,365.00 € |
Estimated delivery in United States, on Thursday 10 Apr 2025
